Congress’ Diabetes Caucus Seeks Transparency, Value-Based Contracts to Control Insulin Prices

Value-based contracts and alternative payment models that remove rebates are just 2 ways that policy makers could rein in skyrocketing insulin prices, according to a new report from the Congressional Diabetes Caucus, a bipartisan group that spent a year https://www.ajmc.com/newsroom/congress-diabetes-caucus-seeks-transparency-valuebased-contracts-to-control-insulin-prices